List view / Grid view

Eli Lilly and Company

Lilly boosts oral GLP-1 manufacturing capability with new Netherlands facility

4 November 2025 | By Catherine Eckford (European Pharmaceutical Review)

The €2.6 billion manufacturing investment complements the recent US manufacturing expansion for its next potential blockbuster obesity treatment orforglipron.

news

Lilly AI factory to accelerate pharmaceutical manufacturing and development

29 October 2025 | By Catherine Eckford (European Pharmaceutical Review)

Pharma giant plans to harness its “decades of data” and use AI to set a new scientific standard that accelerates pharmaceutical innovation.

news

Lilly’s baricitinib exhibits paediatric potential in major alopecia areata study

24 October 2025 | By Catherine Eckford (European Pharmaceutical Review)

Results from the phase III study signify a successful collaboration with biopharma firm Incyte.

news

Lilly outlines $1bn India manufacturing expansion

8 October 2025 | By Dominic Tyer (European Pharmaceutical Review)

The investment will cover CMO collaborations and a new manufacturing and quality hub in Hyderabad.

news

Lilly wins European Alzheimer’s approval for Kisunla after regulatory setbacks

26 September 2025 | By Catherine Eckford (European Pharmaceutical Review)

The anti-amyloid monoclonal antibody is part of the class of medicines representing the first disease-modifying therapies for the neurodegenerative disease.

news

Lilly to site next US manufacturing facility in Texas

24 September 2025 | By Catherine Eckford (European Pharmaceutical Review)

The new $6.5 billion Houston site will manufacture active pharmaceutical ingredients (APIs) in support of the company’s pipeline of small molecule medicines.

Doctor measuring the stomach of an overweight man

news

Pfizer acquires Metsera and its GLP-1 candidates in new $4.9bn obesity play

23 September 2025 | By Dominic Tyer (European Pharmaceutical Review)

The deal with the US biopharma adds a portfolio of clinical-stage incretin and amylin research programmes to its pipeline.

news

Lilly picks Virginia for the first of its four new US manufacturing facilities

17 September 2025 | By Catherine Eckford (European Pharmaceutical Review)

The new $5 billion manufacturing site is set to become the company’s first integrated facility for API and drug product manufacturing.

news

Pharma’s UK dissatisfaction mounts as Merck & Co axes $1.3bn expansion

15 September 2025 | By Dominic Tyer (European Pharmaceutical Review)

Biotech and research investments from Lilly and AstraZeneca also put on hold as pricing row rumbles on.

news

Teva wins US obesity approval for its GLP-1 generic liraglutide

29 August 2025 | By Catherine Eckford (European Pharmaceutical Review)

And Eli Lilly and Company’s new oral GLP-1 obesity therapy orforglipron shines in late-phase clinical trials.

news

Eli Lilly neuroscience executive Anne White to retire

21 August 2025 | By Catherine Eckford (European Pharmaceutical Review)

Her leadership experience spans three decades with Lilly, across multiple therapeutic areas including oncology, neuroscience and infectious disease.

news

Pharma cautious about rushing towards direct-to-consumer drug sales

19 August 2025 | By Catherine Eckford (European Pharmaceutical Review)

Disruption to traditional distribution channels is anticipated to hinder widespread adoption of the channel.

news

Lilly to sell off Branchburg site as its US manufacturing plans take shape

8 August 2025 | By Dominic Tyer (European Pharmaceutical Review)

The pharma company’s digital innovation efforts also progress with the opening of a new Hyderabad facility.

news

Extension trial demonstrates long-term benefit for Lilly Alzheimer’s drug

30 July 2025 | By Catherine Eckford (European Pharmaceutical Review)

The new findings support a limited duration dosing approach and highlight the consistent safety profile for Eli Lilly’s antibody drug.

article

What will shape the Pharma landscape in Q3 2025?

24 July 2025 | By European Pharmaceutical Review

Upcoming drug approvals and clinical progress will be pivotal during the third quarter of the year, says GlobalData.

Cookie	Description
cookielawinfo-checkbox-advertising-targeting	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Description
cf_ob_info	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	This cookie is set by Youtube and is used to track the views of embedded videos.

Cookie	Description
bcookie	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	This cookie is set by LinkedIn and used for routing.
lissc	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Description
advanced_ads_browser_width	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Recommended

Eli Lilly and Company